Home | View Cart | Shipping | Privacy | Drug Testing Help
To purchase products or request more information please email: info@drug-testing-products.com

drug test * drug testing * employee drug testing * urine test * marijuana drug test * urine drug test * hair drug test * drug test * drug test kit * saliva drug test * panel drug testing

Urine Drug Testing
Multi Drug Testing Kits
Multi Drug Testing Cup
Dip Strip Drug Testing
Saliva Drug Test
Drug Testing Info
Drug Testing Overview
Drug Testing  Law
Drug Testing in the workplace
Methods of Drug Testing
Drug Testing in Schools
Drug Testing Statistics
Drug Use Trends

10-panel urine drug test procedure.

  • Please read the enclosed insert completely.

  • Do not open the multi-drug test kit pouch until just prior to testing.

  • Collect a urine sample in a specimen container.

  • Check the expiration date and remove the test device from the sealed pouch. Do not use the test with expirate date. Remove the test cap exposing the 10 absorbent strips. Do not touch the strips or pollute them.

  • Dip the wicks only into the urine sample for approximately 20-30 seconds until visible sample migration up the wicks and across the tests panels is observed

  • Dip only the strips and do not let the sample to come in contact with any other part of the test device or its plastic housing.

  • Read result within 3 to 8 minutes after the addition of samples. Do not read result after 8 minutes. If the drug test is left standing for longer than 8 minutes, the intensity of the colored lines may change or for technical reasons, a faint line may appear that should not be interpreted.

  • Photocopy both sides of the test card for a permanent record of test results.

PRINCIPLE OF THE TEST:  The Multi-drug InstaStrip Test is a competitive binding immunoassay in which drug and drug metabolites in a urine sample compete with immobilized drug conjugate for limited labeled antibody binding sites. By utilizing antibodies that are specific to different drug classes, the test permits independent, simultaneous detection of six drugs from a single sample. The approximate run time is 5 minutes. In the assay procedure, urine mixes with labeled antibody-dye conjugate and migrates along a porous membrane. When the concentration of a given drug is below the detection limit of the test, unbound antibody-dye conjugate binds to antigen conjugate immobilized on the membrane, producing a rose-pink color band in the appropriate Test Zone for that drug. Conversely, when the drug level is at or above the detection limit, free drug competes with the immobilized antigen conjugate on the membrane by binding to antibody-dye conjugate, forming an antigen- antibody complex, preventing the development of a rose-pink color band. Regardless of the drug levels in the sample, a rose-pink color band is produced in each Control Zone (marked C) by a parallel immunochemical reaction. These bands serve as built-in quality control measures by demonstrating antibody recognition, verifying that the reagents are chemically active. that the reagents are chemically active. REAGENTS AND MATERIALS PROVIDED 1. Test Devices. Contains dye-conjugated antibody and immobilized antigen in protein matrix with sodium azide. Optional: Negative Control I. Contains buffered protein solution with sodium azide. PCP Positive Control. Contains PCP at 100 ng/ml in a buffered protein solution with sodium-azide. Marijuana Positive Control Contains THC at 150 ng/ml in a buffered solution with sodium azide. Opiates Positive Control Contains MOR at 1000 ng/ml in a buffered protein solution with sodium azide. Cocaine Positive Control Contains BEG at 1000 ng/ml in a buffered protein solution with sodium azide. Methamphetamine Positive Control Contains MET at 1500 ng/ml in a buffered protein solution with sodium azide. Amphetamine Positive Control Contains AMP at 3000 ng/ml in a buffered protein solution with sodium azide.

WARNINGS AND PRECAUTIONS 1. For in vitro diagnostic and professional use only. 2. Do not use the test device beyond the expiration date. 3. Urine specimens may be infectious; properly handle and dispose of all used reaction devices in a biohazard container. 4. Visually inspect the foil package to insure it is intact. If the package is not intact, the integrity of the device might be compromised.

STORAGE AND STABILITY:  Store test kit below 28C; do not freeze. Refer to the expiration date for stability. TEST PROCEDURE 1. Bring a urine sample and a foil test pouch to room temperature (15-28C). 2. Do not break the seal of the pouch until ready to begin testing. 3. Remove a Test Device from the foil pouch. 4. Remove the protective cap and place the revealed strips into the urine sample for 10 seconds. Do not allow the urine level to touch the plastic device. 5. Read the results at 3-5 minutes. Note: The result must be interpreted at five minutes. Waiting more than five minutes may cause the reading to be inaccurate. To avoid confusion, discard the test device after interpreting the result. INTERPRETATION OF RESULTS


Positive: A rose-pink band is visible in each control zone. No color band appearing in the appropriate test zone indicates a positive result for the corresponding drug of that specific test zone. Negative: A rose-pink band is visible in each control zone and the appropriate test zone, indicating that the concentration of the corresponding drug of that specific test zone is below the detection limit of the test. Invalid: If a color band is not visible in each of the control zones, the test is invalid. Another test should be run to re-evaluate the specimen. Note: There is no meaning attributed to line color intensity or width.

QUALITY CONTROL:  An internal procedure control has been incorporated into the test to ensure proper kit performance and reliability. The use of an external control is recommended to verify proper kit performance. Quality control samples should be tested according to quality control requirements established by the testing laboratory.

LIMITATIONS OF THE TEST 1. This product is designed to be used for the detection of drugs of abuse and their metabolites in human urine only. 2. Although the test is very accurate, there is the possibility false results will occur due to the presence of interfering substances in the specimen sample. 3. The test is a qualitative screening assay and is not suggested for quantitative determination of drug levels in urine, or the level of intoxication. 4. Adulterants such as bleach or other strong oxidizing agents, when added to urine specimens can cause erroneous test results regardless of the analysis method used. If adulteration is suspected, obtain another urine specimen.

PERFORMANCE CHARACTERISTICS 1. Sensitivity. The Multi-drug InstaStrip Testdetects drugs of abuse and their major metabolites in urine at concentrations equal to or greater than the cut-off level for the specific drug, which is suggested by the National Institute on Drug Abuse (NIDA) for the immunoassay method.

2. Specificity. A study was conducted with the Multi-drug InstaStrip Test to determine the cross-reactivity of drug-related compounds with the test. Substances listed in Table I produced results approximately equivalent to the cutoff levels. A separate study was conducted to determine the cross-reactivity of non-related compounds with the test at concentrations much higher than normally found in the urine of people using or abusing them. No cross reactivity was detected with the substances listed in Table II.

3. Accuracy: The accuracy of the Multi-drug Multi-drug InstaStrip Testwas first tested in urine samples in-house and subsequently in a clinical trial of urine samples submitted to a NIDA certified laboratory. In both cases the laboratories used EMIT II as their screening procedure. All positive samples by either screening method were confirmed by GC/MS.




 Please Email Us: info@drug-testing-products.com


Copyright www.drug-testing-products.com 2004 All right reserved